Polaris Venture Management Co. V as of June 30, 2015
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 9 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| T2 Biosystems | 16.4 | $37M | 2.3M | 16.23 | |
| Pulmatrix | 15.4 | $35M | 3.6M | 9.60 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 15.1 | $34M | 1.8M | 18.52 | |
| Genocea Biosciences | 12.1 | $27M | 2.0M | 13.73 | |
| Ocular Therapeutix (OCUL) | 11.5 | $26M | 1.2M | 21.03 | |
| Trevena | 10.5 | $24M | 3.8M | 6.26 | |
| Fate Therapeutics (FATE) | 7.1 | $16M | 2.5M | 6.47 | |
| Cerulean Pharma | 6.7 | $15M | 3.3M | 4.60 | |
| Bind Therapeutics | 5.0 | $11M | 2.0M | 5.59 |
